Breakthrough Cutaneous Crohn's Disease Healed with Risankizumab

被引：0
|
作者：
Brennan, Kristen [1 ]
Stein, Daniel J. [1 ]
Roth, Gretchen [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001044720.32191.d6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S2513 / S2513
页数：1
相关论文
共 50 条
  • [21] Dose Intensification of Risankizumab for Crohn's Disease: Access and Outcomes
    Dalal, Rahul
    Cabral, Heidy
    Carlin, Alexander
    Allegretti, Jessica R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1076 - S1077
  • [22] Outcomes After Dose Intensification of Risankizumab for Crohn's Disease
    Dalal, Rahul s.
    Cabral, Heidy j.
    Carlin, Alex
    Ilse, Matthew p.
    Allegretti, Jessica r.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (04)
  • [23] Study of the Effects of Risankizumab in Moderate to Severe Crohn's Disease
    Fang, Yuan
    Li, Jipeng
    Wu, J.
    Zhang, Luxi
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 230 - 235
  • [24] Successful treatment of concomitant Crohn's disease and psoriasis with risankizumab
    Tursi, Antonio
    Florio, Tommaso
    Tiano, Michele
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (11) : 1462 - +
  • [25] Efficacy and Safety of Risankizumab in the Treatment of Crohn's Disease of the Pouch
    Lan, Nan
    Shen, Bo
    ACG CASE REPORTS JOURNAL, 2024, 11 (09)
  • [26] Cutaneous Crohn's disease:: 'metastatic Crohn's is a misnomer'
    Anadolu, R
    Çalikoglu, E
    Karayalçin, S
    Gürgey, E
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 1999, 13 (01) : 67 - 68
  • [27] Risankizumab (Skyrizi) - An IL-23 Antagonist for Crohn's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2022, 64 (1666): : 205 - 207
  • [28] Risankizumab versus ustekinumab for Crohn's disease: a phase IIIb study
    Kotsiliti, Eleni
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2024, 21 (09) : 606 - 606
  • [29] Efficacy and safety of risankizumab in children with Crohn's disease: A preliminary report
    Spencer, E.
    Stein, R.
    Shalem, T.
    Zifman, E.
    Dubinsky, M.
    Tzion, R. Lev
    Turner, D.
    Assa, A.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1435 - I1436
  • [30] Crohn's Disease: Risankizumab as Induction- and Maintenance Therapy Comment
    Atreya, Raja
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (17) : 1086 - 1087
12345